DANISH BIO – DANSK BIOTEK organizes four major plenary meetings for our members throughout the year to increase our members' knowledge regarding specific biotech topics and to facilitate networking. The events usually take place in February, May, September and November.

We also organize approximately four "saloon" meetings annually. They are small, intimate, "meet the expert" meetings with typically 6-20 participants advocating more in-depth discussion and knowledge-sharing on specific themes.

News

Ja, GDPR er superkedeligt! 04 June 2018

Og denne mail er sikkert blot én i rækken af en endeløs mailstrøm, hvor du skal læse og tage stilling... Read more

Symphogen Further Strengthens its Immuno-Oncology Pipeline by Advancing into Two Additional Clinical Trials 31 May 2018

Seventh Program to enter Clinical Development at Symphogen Symphogen’s antibody platform is now validated... Read more

Generalforsamling 9. maj 2018 og godkendt Årsregnskab 2017 19 May 2018

DANISH BIO – DANSK BIOTEK afholdt i år ordinær generalforsamling den 9. maj hos Novo i forbindelse... Read more

Generalforsamling i DANISH BIO – DANSK BIOTEK den 9. maj 2018 21 March 2018

Den 9. maj 2018 kl. 13.30 hos NOVO, Tuborg Havnevej 19, 2900 Hellerup Dagsorden c.f. vedtægterne: a. ... Read more

Formanden har ordet: Vækstplan for life science vil gøre en forskel 20 March 2018

For et par uger siden præsenterede regeringen sin længe ventede Vækstplan for life science. I DANISH... Read more

Acesion Pharma Receives Approval for Phase I Study in Atrial Fibrillation 08 February 2018

Appoints Internationally Renowned Scientific Advisors COPENHAGEN, Denmark— 8 February 2018: Acesion... Read more

Symphogen Receives Milestone Payment for Initiation of Phase 1b Trial in Infectious Disease 30 November 2017

COPENHAGEN, Denmark (November 30, 2017) – Symphogen, a private clinical late-stage antibody oncology-focused... Read more

YmAbs Announces Closing of $30 Million Extension of Private Equity Placement 29 November 2017

Common stock placement extended to a total of $80 million as Sofinnova Ventures and Scopia Capital Management... Read more

Formanden har ordet: Godt gået Orphazyme! 29 November 2017

For knap to uger siden lykkedes det Orphazyme at gå på Børsen i København! Selskabet solgte 7,5 mio.... Read more

Copyright 2017 DANISH BIO – DANSK BIOTEK. All rights reserved.

created by: Mastafu Design